Literature DB >> 31836854

Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract.

Guangzhen Hu1, Jessica L Phillips1, Surendra Dasari2, Hailey K Jacobs1, Rebecca A Luchtel1, Naoki Oishi1,3, Tanya Hundal1, Nada H Ahmed1,4, Akira Satou1,5, Alan L Epstein6, N Nora Bennani7, Grzegorz S Nowakowski7,8, Joseph A Murray9, Andrew L Feldman10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31836854      PMCID： PMC7196010          DOI： 10.1038/s41375-019-0678-3

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  1 in total

Review 1.  Chromosomal translocations involved in non-Hodgkin lymphomas.

Authors:  Francisco Vega; L Jeffrey Medeiros
Journal:  Arch Pathol Lab Med       Date:  2003-09       Impact factor: 5.534
  1 in total
  1 in total

1.  Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.

Authors:  Andrés E Quesada; Yanming Zhang; Ryan Ptashkin; Caleb Ho; Steven Horwitz; Ryma Benayed; Ahmet Dogan; Maria E Arcila
Journal:  Breast J       Date:  2021-02-18       Impact factor: 2.431
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.